Whitepapers and videos

Product

• 

  Case Study

  Bolt Threads: Optimizing Biomaterials R&D

  Bolt Threads is revolutionizing fabrics with bioengineered materials. Read how Bolt uses Benchling to centralize data, streamline R&D, and gain insights that drive decision making.

  Learn more

• 

  Blog

  Benchling: Bringing biointelligence to life science R&D

  We're thrilled to announce Benchling’s Series C fundraising, led by Menlo Ventures and joined by Lead Edge Capital and YC Continuity. In this post, we discuss our plans for Benchling as we enter this new stage of growth, and how biointelligence is crucial for the companies that are redefining modern life science.

  Learn more

• 

  Case Study

  Adicet Bio: Building a Data Infrastructure for Next-Generation Cell Therapies

  Adicet Bio is building the next generation of cellular therapies with gamma delta T cells. With Benchling, Adicet Bio now has a data infrastructure that ensures their data's integrity, allows them to efficiently file for IND, and is set to scale as their team grows and their research expands.

  Learn more

• 

  Video

  Sitting Down with Adicet Bio: Building a Data Infrastructure for Cellular Therapies

  Watch the interview with Jeannette Grant of Adicet Bio where she shares how Adicet uses Benchling to ensure their data's integrity which prepares them for IND filing and ultimately helps them bring their therapies to the clinic.

  Watch Now

• 

  Video

  Webinar: High-Throughput DNA Sequence Design for Modern Molecular Biology Workflows

  Successful companies have embraced the complexity of molecular biology by building collaborative teams to carry out high-throughput research. These teams urgently need automated sequence design and analysis tools. Watch this webinar to see how Benchling Bulk DNA Assembly — a tool for modeling high-throughput combinatorial cloning in silico — accelerates molecular biology workflows.

  Watch Now

• 

  Video

  A Conversation with Bolt Threads

  We sat down with Bolt Threads’ Deven Dharm, Director of Software Engineering, and Patrick Johnson, Systems Analyst, to hear how Bolt uses Benchling to manage its data. With Benchling, Bolt tracks the lineage of entities and their data, significantly speeds up data entry, and eliminates data errors by 30%.

  Watch Now

• 

  Video

  Adicet Bio: Building the Next Generation of Cellular Therapies

  Adicet Bio is harnessing the innate allogeneic potential of gamma delta (γδ) T cells to treat solid and liquid tumors. At Benchtalk West, Adicet discussed the unique challenges in developing these cutting-edge therapeutics, and how Benchling is changing the way Adicet organizes and carries out R&D.

  Watch Now

• 

  Video

  Bolt Threads: Leveraging Data to Engineer Revolutionary, Nature-Inspired Materials

  Bolt Threads is harnessing proteins found in nature to create materials with both practical and revolutionary uses. At Benchtalk West, Bolt outlined how they work with Benchling to simplify R&D informatics and empower their scientists with a flexible and reliable platform.

  Watch Now

• 

  Whitepaper

  How to Upgrade from Vector NTI to Benchling

  In the past decade, molecular biology has evolved tremendously, but sequence design software has stagnated. In this whitepaper, we discuss how you can digitally transform your molecular biology with Benchling’s modern, cloud-based platform.

  Learn more

• 

  Whitepaper

  Benchling for Gene Therapy and Gene Editing R&D

  Gene therapy, nucleotide therapy, and gene editing technologies encompass a wide range of products, including plasmid DNA, viral vectors, bacterial vectors, oligonucleotides (short-strand DNA and RNA), siRNA, CRISPR, ZFNs, and TALENs. These products have been of significant research interest, especially with the recent approval of breakthrough therapies like Luxturna. However, several hurdles persist for companies seeking to develop these novel therapies.

  Learn more

• 

  Whitepaper

  Benchling for Cell Therapy R&D

  Cell therapies such as stem cells, CAR T cells, and TCR have been of significant interest in research over the past few decades. The recent FDA approvals of CAR T therapies have led to renewed interest in the field. As companies rush to bring more novel cell therapies to the market, they face several R&D complexities. This paper outlines the critical needs and complexities of cell therapy R&D, and how Benchling has helped address these challenges for leading cell therapy companies.

  Learn more

• 

  Whitepaper

  Benchling Security Overview

  Benchling’s commitment to data security is central to our company. Our success depends on earning and keeping your trust, and we take that very seriously. We know that trust starts with confidence that your company’s data is safe with us. This document outlines how Benchling keeps your company's data safe.

  Learn more

• 

  Whitepaper

  Benchling for Antibody Therapeutics R&D

  Antibodies are an important class of therapeutic agents which have evolved significantly over the past 30 years. Antibody R&D is now more streamlined than ever, but several factors continue to contribute to its complexity. This paper outlines the critical needs and complexities faced during both research and development phases, and how Benchling has helped address these challenges for leading antibody companies.

  Learn more

• 

  Video

  Obsidian Therapeutics: Unlocking pivotal R&D answers

  Obsidian’s legacy sample tracking system was unintuitive and saw low scientist usage, leading to data loss and compliance concerns. Hear how Benchling’s integrated sample tracking and notetaking generated strong user adoption, improved the quality and reliability of experimental records, and empowers Obsidian to extract learnings from their data that they otherwise wouldn’t have.

  Watch Now

• 

  eBook

  Customer Success Snapshots

  From California, to Korea, to the Netherlands, companies developing large molecule-based products rely on Benchling to accelerate R&D and generate unprecedented business insights. In this eBook, we cover stories from Incyte, Intellia Therapeutics, Agenus, Warp Drive Bio, Zymergen, Obsidian Therapeutics, and Inhibrx.

  Learn more

• 

  eBook

  Rubius: Optimizing Cell Engineering with a Unified Informatics Platform

  Rubius Therapeutics is engineering therapeutic red blood cells to treat a host of diseases, using varied, complex cell engineering processes to do so. Before Benchling, it was difficult for Rubius to unify these discrete steps in cellular engineering, and it left their teams out of sync. After adopting Benchling, Rubius can now collaborate and manage their pipeline, all with one unified platform.

  Learn more

• 

  Case Study

  Synlogic: Accelerating Synthetic Biology with Fully Unified Informatics

  Synlogic is employing naturally occurring, non-pathogenic bacteria from the human gut microbiome by genetically altering them to function as living medicines. Previously, Synlogic’s legacy software was hindering data processing and reporting. Then Synlogic adopted Benchling, which enabled them to automate and structure their data capture in a single centralized system.

  Learn more

• 

  Case Study

  Agenus: Building a Global Informatics Infrastructure

  Agenus is a global biopharmaceutical company with scientific staff spread across four discovery, screening, and characterization facilities around the world. Without unified informatics systems, it was difficult for Agenus's scientists to effectively find and share information. Learn how Benchling replaced Agenus's multiple informatics systems with a single, end-to-end platform.

  Learn more

• 

  Case Study

  Zymergen: Integrating the custom solutions of a technology powerhouse

  Zymergen is an industrial biotechnology company with many custom software systems and algorithms. Prior to adopting Benchling, Zymergen's scientists had to enter and extract data across many siloed pieces of custom software. Today, Zymergen uses Benchling as a central platform to unite their custom tools and collaborate seamlessly across teams.

  Learn more

• 

  Case Study

  Arcturus: Enhancing research productivity by 30%

  Arcturus is an industry leader in RNA medicines. Without standardized molecular design tools, scientists struggled to collaborate and share their sequences. And with their legacy ELN, it took an average of 10 days for experimental data to be recorded. With Benchling, Arcturus saw a dramatic increase in scientist collaboration and reduced time to data entry by 85%.

  Learn more

• 

  Video

  Benchling Overview

  Watch an overview of the key features of Benchling Notebook, Molecular Biology, Registry, Inventory, Workflows, and Requests.

  Watch Now

• 

  Video

  Webinar: Scaling Your Biologics R&D Programs

  Dennis Underwood, VP of Molecular Information Systems at Agenus, and Sajith Wickramasekara, CEO and Co-Founder of Benchling, discuss best practice strategies to streamline R&D operations.

  Watch Now

• 

  Video

  Introducing Registry

  Learn how to model the complexity of any large molecule entity in Benchling Registry. From bacteria and yeast strains, to antibody complexes, Registry can manage any biological entity, reagent, instrument, and more.

  Watch Now

• 

  Video

  Introducing Requests

  Learn how to submit requests and link relevant input samples; prioritize requests for your teams; fulfill similar requests all at once in batches; and run reports on key metrics.

  Watch Now

• 

  Video

  Introducing Workflows

  Organize, optimize, and measure your R&D from early discovery to bioprocessing. Learn about Benchling's tools for workflow design, data capture, progress monitoring, and business intelligence.

  Watch Now

• 

  Video

  Benchling Codeless Configuration

  Learn how to configure biological entities, locations, inventories, workflows, and reports in Benchling's point-and-click interface. Never wait months for a vendor to alter your informatics platform - do it yourself in moments.

  Watch Now

• 

  Video

  Benchling Registry and Molecular Biology for Antibody Engineering

  Learn how our unified Registry, Molecular Biology, and Notebook applications work together to power antibody R&D. Register antibodies and chains; translate between DNA and protein sequences; analyze biochemical properties in real-time.

  Watch Now

• 

  Video

  Benchling Registry and Molecular Biology for Cell and Gene Therapy

  Learn how our unified applications work together to power cell and gene therapy R&D. Drag-and-drop plasmids into Notebook entries; parse sequence features to automatically register plasmids and their components.

  Watch Now

• 

  Video

  Accelerating Synthetic Biology with Fully Unified Informatics

  Scott Hamilton, Senior Lead Process Engineer at Synlogic, talks about how he uses Benchling to integrate bioreactors directly with informatics, and accelerate data capture and analytics.

  Watch Now

• 

  eBook

  Benchling: A Modern Informatics Platform for Large Molecule R&D

  Benchling is natively built to model the complexity of large molecule R&D processes. It's a lasting informatics infrastructure that drives the development of your organization's scientific platform. Learn how Benchling will help you accelerate R&D and make better business decisions.

  Learn more

• 

  Blog

  How to Pick an Electronic Laboratory Notebook

  Benchling has seen use of its ELN in academia more than double for the past two years, with tens of thousands of researchers now logging in every day.

  Learn more

• 

  Whitepaper

  Benchling for Growing Biotech Overview

  Benchling is natively built to model the complexity of biologics processes and samples and provide full experimental context across handoffs. It's a lasting informatics infrastructure that drives the development of your organization's scientific platform.

  Learn more

• 

  Blog

  To Connect or to Integrate: The Role of Informatics in the Lab

  Export functionality and other nominal “connectivity” features displace and stand in for actually useful functionality: meaningful integration between lab informatics software. Many informatics solutions bill themselves as integrated, but more often than not, that supposed integration falls short.

  Learn more